000143834 001__ 143834
000143834 005__ 20240229112609.0
000143834 0247_ $$2doi$$a10.1111/cas.14077
000143834 0247_ $$2pmid$$apmid:31119819
000143834 0247_ $$2ISSN$$a0910-5050
000143834 0247_ $$2ISSN$$a1344-6428
000143834 0247_ $$2ISSN$$a1347-9032
000143834 0247_ $$2ISSN$$a1349-7006
000143834 0247_ $$2ISSN$$a1876-4673
000143834 0247_ $$2altmetric$$aaltmetric:73955141
000143834 037__ $$aDKFZ-2019-01396
000143834 041__ $$aeng
000143834 082__ $$a610
000143834 1001_ $$aSpartalis, Christoph$$b0
000143834 245__ $$aIn vivo effects of chemotherapy on oncogenic pathways in colorectal cancer.
000143834 260__ $$aTokyo$$bAssoc.$$c2019
000143834 3367_ $$2DRIVER$$aarticle
000143834 3367_ $$2DataCite$$aOutput Types/Journal article
000143834 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1681891607_17224
000143834 3367_ $$2BibTeX$$aARTICLE
000143834 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143834 3367_ $$00$$2EndNote$$aJournal Article
000143834 520__ $$aPatients with advanced colorectal cancer often are treated with systemic cytotoxic therapy using fluouracil (5-FU), oxaliplatin, irinotecan, and FOLFOX or FOLFIRI combination protocols. Additionally, signaling pathways that are active in colorectal cancer can be therapeutically targeted. Here, we examined if chemotherapy impacts on WNT, MAPK and NOTCH signaling pathways in xenograft models of colon cancer. Furthermore, we tested if combining chemotherapy with MAPK and NOTCH inhibition has superior therapeutic effects. We demonstrate that tumor cells with high WNT, MAPK and NOTCH activity are variably affected by different chemotherapeutic regimens, while vital tumor cells with different pathway activity remain in treated colon cancer xenografts. Although this provided a rationale to additionally target pathway activity, we found no significant increase in therapy response when combining MAPK and NOTCH inhibition with fluouracil chemotherapy. We attribute this finding to a decrease in tumor cell proliferation upon MAPK and NOTCH inhibition, resulting in reduced effectiveness of cytotoxic treatment. Therapeutic benefits of combining chemotherapy with targeting of signaling pathways that are active in colon cancer thus must be critically evaluated for patients with colorectal cancer. This article is protected by copyright. All rights reserved.
000143834 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000143834 588__ $$aDataset connected to CrossRef, PubMed,
000143834 7001_ $$aSchmidt, Eva Marina$$b1
000143834 7001_ $$aElmasry, Manal$$b2
000143834 7001_ $$aSchulz, Gerald Bastian$$b3
000143834 7001_ $$0P:(DE-He78)fd68f49dada874ac262fadf9fde869df$$aKirchner, Thomas$$b4
000143834 7001_ $$0P:(DE-HGF)0$$aHorst, David$$b5
000143834 773__ $$0PERI:(DE-600)2115647-5$$a10.1111/cas.14077$$gp. cas.14077$$n8$$p2529-2539$$tCancer science$$v110$$x1349-7006$$y2019
000143834 909CO $$ooai:inrepo02.dkfz.de:143834$$pVDB
000143834 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fd68f49dada874ac262fadf9fde869df$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000143834 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000143834 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000143834 9141_ $$y2019
000143834 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143834 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143834 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000143834 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143834 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER SCI : 2017
000143834 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000143834 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000143834 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review
000143834 915__ $$0LIC:(DE-HGF)CCBYNCNDNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)$$bDOAJ
000143834 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143834 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143834 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143834 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143834 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000143834 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143834 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000143834 9201_ $$0I:(DE-He78)E131-20160331$$kE131$$lComputer-assistierte Interventionen$$x0
000143834 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x1
000143834 9201_ $$0I:(DE-He78)L201-20160331$$kL201$$lDKTK Berlin$$x2
000143834 980__ $$ajournal
000143834 980__ $$aVDB
000143834 980__ $$aI:(DE-He78)E131-20160331
000143834 980__ $$aI:(DE-He78)L101-20160331
000143834 980__ $$aI:(DE-He78)L201-20160331
000143834 980__ $$aUNRESTRICTED